Rapid desensitization of mice with anti-FcγRIIb/FcγRIII mAb safely prevents IgG-mediated anaphylaxis

Journal of Allergy and Clinical Immunology

Volumn 132, Issue 6, 2013, Pages 1375-1387

  Khodoun, Marat V ^a,b   Kucuk, Zeynep Yesim ^c   Strait, Richard T ^a,c   Krishnamurthy, Durga ^a,b   Janek, Kevin ^b   Clay, Corey D ^b   Morris, Suzanne C ^a,b   Finkelman, Fred D ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Anaphylaxis; basophil; Fc R; IgG; macrophage; mouse; neutrophil; rapid desensitization

Indexed keywords

BIOTIN; BOVINE SERUM ALBUMIN; CD16 ANTIGEN; EGG WHITE; FC RECEPTOR IIB; HYDROXYUREA; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2.4G2; RECOMBINANT INTERLEUKIN 4; UNCLASSIFIED DRUG;

ANAPHYLAXIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; BASOPHIL; CELL TYPE; CONTROLLED STUDY; DESENSITIZATION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL; RAPID DESENSITIZATION; RECTUM TEMPERATURE; SURVIVAL; TREATMENT RESPONSE;

EID: 85027953270     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2013.09.008     Document Type: Article

References (60)

1. F. Nimmerjahn, and J.V. Ravetch Fcγ receptors as regulators of immune responses Nat Rev Immunol 8 2008 34 47
2. P. Bruhns Properties of mouse and human IgG receptors and their contribution to disease models Blood 119 2012 5640 5649
3. V.C. Huber, J.M. Lynch, D.J. Bucher, J. Le, and D.W. Metzger Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections J Immunol 166 2001 7381 7388
4. K.M. Chung, G.E. Nybakken, B.S. Thompson, M.J. Engle, A. Marri, and D.H. Fremont Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fcγ receptor-dependent and -independent mechanisms J Virol 80 2006 1340 1351
5. A. Ioan-Facsinay, S.J. de Kimpe, S.M. Hellwig, P.L. van Lent, F.M. Hofhuis, and H.H. van Ojik FcγRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection Immunity 16 2002 391 402
6. A. Bergtold, A. Gavhane, V. D'Agati, M. Madaio, and R. Clynes FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis J Immunol 177 2006 7287 7295
7. D. Meyer, C. Schiller, J. Westermann, S. Izui, W.L. Hazenbos, and J.S. Verbeek FcγRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia Blood 92 1998 3997 4002
8. J.E. Gessner, H. Heiken, A. Tamm, and R.E. Schmidt The IgG Fc receptor family Ann Hematol 76 1998 231 248
9. H.H. Radeke, I. Janssen-Graalfs, E.N. Sowa, N. Chouchakova, J. Skokowa, and F. Loscher Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis J Biol Chem 277 2002 27535 27544
10. E. Tuzun, S.S. Saini, H. Yang, D. Alagappan, S. Higgs, and P. Christadoss Genetic evidence for the involvement of FcγRIII in experimental autoimmune myasthenia gravis J Neuroimmunol 174 2006 157 167
11. T. Hashimoto, N. Ishii, C. Ohata, and M. Furumura Pathogenesis of epidermolysis bullosa acquisita, an autoimmune subepidermal bullous disease J Pathol 228 2012 1 7
12. R.T. Strait, S.C. Morris, M. Yang, X.W. Qu, and F.D. Finkelman Pathways of anaphylaxis in the mouse J Allergy Clin Immunol 109 2002 658 668
13. R.M. Anthony, F. Nimmerjahn, D.J. Ashline, V.N. Reinhold, J.C. Paulson, and J.V. Ravetch Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc Science 320 2008 373 376
14. J. Unkeless Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors J Exp Med 150 1979 580 596
15. M. Hirano, R.S. Davis, W.D. Fine, S. Nakamura, K. Shimizu, and H. Yagi IgEb immune complexes activate macrophages through FcγRIV binding Nat Immunol 8 2007 762 771
16. J.L. Teeling, T. Jansen-Hendriks, T.W. Kuijpers, M. de Haas, J.G. van de Winkel, and C.E. Hack Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia Blood 98 2001 1095 1099
17. M. Khodoun, Z.Y. Kucuk, R.T. Strait, D. Krishnamurthy, K. Janek, and I.P. Lewkowich Rapid polyclonal desensitization with antibodies to IgE and FcεRIα J Allergy Clin Immunol 133 2013 1555 1564
18. J.V. Ravetch, and S. Bolland IgG Fc receptors Annu Rev Immunol 19 2001 275 290
19. D. Dombrowicz, V. Flamand, K.K. Brigman, B.H. Koller, and J.P. Kinet Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene Cell 75 1993 969 976
20. D.B. Wilde, P. Marrack, J. Kappler, D.P. Dialynas, and F.W. Fitch Evidence implicating L3T4 in class II MHC antigen reactivity: monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines J Immunol 131 1983 2178 2183
21. T. Springer, G. Galfre, D.S. Secher, and C. Milstein Mac-1: a macrophage differentiation antigen identified by monoclonal antibody Eur J Immunol 9 1979 301 306
22. S. Okada, H. Nakauchi, K. Nagayoshi, S. Nishikawa, Y. Miura, and T. Suda Enrichment and characterization of murine hematopoietic stem cells that express c-kit molecule Blood 78 1991 1706 1712
23. C. Schiller, I. Janssen-Graalfs, U. Baumann, K. Schwerter-Strumpf, S. Izui, and T. Takai Mouse FcγRII is a negative regulator of FcγRIII in IgG immune complex-triggered inflammation but not in autoantibody-induced hemolysis Eur J Immunol 30 2000 481 490
24. F. Nimmerjahn, P. Bruhns, K. Horiuchi, and J.V. Ravetch FcγRIV: a novel FcR with distinct IgG subclass specificity Immunity 23 2005 41 51
25. F.D. Finkelman, S.W. Kessler, J.F. Mushinski, and M. Potter IgD-secreting murine plasmacytomas: identification and partial characterization of two IgD myeloma proteins J Immunol 126 1981 680 687
26. F.D. Finkelman, K.B. Madden, S.C. Morris, J.M. Holmes, N. Boiani, and I.M. Katona Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes J Immunol 151 1993 1235 1244
27. I. Miyajima, D. Dombrowicz, T.R. Martin, J.V. Ravetch, J.P. Kinet, and S.J. Galli Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and FcγRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis J Clin Invest 99 1997 901 914
28. R.T. Strait, W. Hicks, N. Barasa, A. Mahler, M. Khodoun, and J. Kohl MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice J Exp Med 208 2011 2525 2544
29. M. Khodoun, R. Strait, T. Orekov, S. Hogan, H. Karasuyama, and D.R. Herbert Peanuts can contribute to anaphylactic shock by activating complement J Allergy Clin Immunol 123 2009 342 351
30. R.T. Strait, S.C. Morris, K. Smiley, J.F. Urban Jr., and F.D. Finkelman IL-4 exacerbates anaphylaxis J Immunol 170 2003 3835 3842
31. D. Dombrowicz, V. Flamand, I. Miyajima, J.V. Ravetch, S.J. Galli, and J.P. Kinet Absence of FcεRαI chain results in upregulation of FcγRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between FcεRI and FcγRIII for limiting amounts of FcR β and γ chains J Clin Invest 99 1997 915 925
32. F. Jonsson, D.A. Mancardi, Y. Kita, H. Karasuyama, B. Iannascoli, and N. Van Rooijen Mouse and human neutrophils induce anaphylaxis J Clin Invest 121 2011 1484 1496
33. Y. Tsujimura, K. Obata, K. Mukai, H. Shindou, M. Yoshida, and H. Nishikado Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis Immunity 28 2008 581 589
34. D.A. Mancardi, B. Iannascoli, S. Hoos, P. England, M. Daeron, and P. Bruhns FcγRIV is a mouse IgE receptor that resembles macrophage FcεRI in humans and promotes IgE-induced lung inflammation J Clin Invest 118 2008 3738 3750
35. R.T. Strait, S.C. Morris, and F.D. Finkelman IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb cross-linking J Clin Invest 116 2006 833 841
36. T.A. Waldmann, and W. Strober Metabolism of immunoglobulins Prog Allergy 13 1969 1 110
37. S. Bolland, and J.V. Ravetch Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis Immunity 13 2000 277 285
38. H. Yoshida, K. Satoh, M. Koyama, M. Hiramoto, and S. Takamatsu Deficiency of plasma platelet-activating factor acetylhydrolase: roles of blood cells Am J Hematol 53 1996 158 164
39. A.P. Schmidt, H.F. Taswell, and G.J. Gleich Anaphylactic transfusion reactions associated with anti-IgA antibody N Engl J Med 280 1969 188 193
40. A. Cheifetz, M. Smedley, S. Martin, M. Reiter, G. Leone, and L. Mayer The incidence and management of infusion reactions to infliximab: a large center experience Am J Gastroenterol 98 2003 1315 1324
41. E. Miele, J.E. Markowitz, P. Mamula, and R.N. Baldassano Human antichimeric antibody in children and young adults with inflammatory bowel disease receiving infliximab J Pediatr Gastroenterol Nutr 38 2004 502 508
42. F. Baert, M. Noman, S. Vermeire, G. Van Assche, G. D'Haens, and A. Carbonez Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease N Engl J Med 348 2003 601 608
43. H. Hedin, W. Richter, K. Messmer, H. Renck, K.G. Ljungstrom, and H. Laubenthal Incidence, pathomechanism and prevention of dextran-induced anaphylactoid/anaphylactic reactions in man Dev Biol Stand 48 1980 179 189
44. Y. Umeda, Y. Fukumoto, T. Miyauchi, M. Imaizumi, K. Shimabukuro, and Y. Mori Anaphylactic shock related to aprotinin induced by anti-aprotinin immunoglobulin G antibody alone; report of a case Kyobu Geka 60 2007 69 71
45. L. Bergamaschini, P.M. Mannucci, A.B. Federici, R. Coppola, S. Guzzoni, and A. Agostoni Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor J Lab Clin Med 125 1995 348 355
46. G. Camussi, M. Aglietta, R. Coda, F. Bussolino, W. Piacibello, and C. Tetta Release of platelet-activating factor (PAF) and histamine, II: the cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils Immunology 42 1981 191 199
47. M. Sanchez-Crespo, F. Alonso, and J. Egido Platelet-activating factor in anaphylaxis and phagocytosis, I: release from human peripheral polymorphonuclears and monocytes during the stimulation by ionophore A23187 and phagocytosis but not from degranulating basophils Immunology 40 1980 645 655
48. G. Camussi, F. Bussolino, C. Tetta, W. Piacibello, and M. Aglietta Biosynthesis and release of platelet-activating factor from human monocytes Int Arch Allergy Appl Immunol 70 1983 245 251
49. P. Vadas, M. Gold, B. Perelman, G.M. Liss, G. Lack, and T. Blyth Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis N Engl J Med 358 2008 28 35
50. P. Vadas, B. Perelman, and G. Liss Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis J Allergy Clin Immunol 131 2012 144 149
51. T. Araujo-Jorge, M.T. Rivera, A. eI Bouhdidi, M. Daeron, and Y. Carlier An FcγRII-, FcγRIII-specific monoclonal antibody (2.4G2) decreases acute Trypanosoma cruzi infection in mice Infect Immun 61 1993 4925 4928
52. C. Ouma, G.C. Davenport, S. Garcia, P. Kempaiah, A. Chaudhary, and T. Were Functional haplotypes of Fc gamma (Fcγ) receptor (FcγRIIA and FcγRIIIB) predict risk to repeated episodes of severe malarial anemia and mortality in Kenyan children Hum Genet 131 2012 289 299
53. J. Sole-Violan, M.I. Garcia-Laorden, J.A. Marcos-Ramos, F.R. de Castro, O. Rajas, and L. Borderias The Fcγ receptor IIA-H/H131 genotype is associated with bacteremia in pneumococcal community-acquired pneumonia Crit Care Med 39 2011 1388 1393
54. H. Endeman, M.C. Cornips, J.C. Grutters, J.M. van den Bosch, H.J. Ruven, and H. van Velzen-Blad The Fcγ receptor IIA-R/R131 genotype is associated with severe sepsis in community-acquired pneumonia Clin Vaccine Immunol 16 2009 1087 1090
55. P. Domingo, E. Muniz-Diaz, M.A. Baraldes, M. Arilla, N. Barquet, and R. Pericas Associations between Fcγ receptor IIA polymorphisms and the risk and prognosis of meningococcal disease Am J Med 112 2002 19 25
56. A.M. Yee, H.M. Phan, R. Zuniga, J.E. Salmon, and D.M. Musher Association between FcγRIIa-R131 allotype and bacteremic pneumococcal pneumonia Clin Infect Dis 30 2000 25 28
57. F. Pinheiro da Silva, M. Aloulou, D. Skurnik, M. Benhamou, A. Andremont, and I.T. Velasco CD16 promotes Escherichia coli sepsis through an FcRγ inhibitory pathway that prevents phagocytosis and facilitates inflammation Nat Med 13 2007 1368 1374
58. M. de Haas, M. Kleijer, R. van Zwieten, D. Roos, and A.E. von dem Borne Neutrophil FcγRIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families Blood 86 1995 2403 2413
59. J.G. van de Winkel, T.P. de Wit, L.K. Ernst, P.J. Capel, and J.L. Ceuppens Molecular basis for a familial defect in phagocyte expression of IgG receptor I (CD64) J Immunol 154 1995 2896 2903
60. A. Ujike, Y. Ishikawa, M. Ono, T. Yuasa, T. Yoshino, and M. Fukumoto Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG J Exp Med 189 1999 1573 1579